Literature DB >> 26994053

A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.

Mark Anthony Sandoval1, Daveric Pagsisihan2, A'Ericson Berberabe3, Elaine Gayle Palugod-Lopez4.   

Abstract

Most cases of insulinomas are benign. We report a case of a malignant form of insulinoma. A 46-year-old man presented with behavioural changes associated with hypoglycaemia. Diagnostic work up revealed high serum insulin, high C-peptide and low glucose levels, compatible with endogenous hyperinsulinaemic hypoglycaemia. CT imaging of the abdomen revealed a pancreatic head mass and multiple liver masses. Biopsy of the pancreatic mass revealed a grade three pancreatic neuroendocrine carcinoma. Histological analysis of a liver mass showed that it was identical to the pancreatic mass, confirming its metastatic nature. The patient underwent distal pancreatectomy with en bloc splenectomy. There was persistence of hypoglycaemic symptoms after removal of the pancreatic mass, suggesting that the liver metastases were also functioning. Symptoms were controlled by diazoxide and octreotide long-acting release. The patient is already 1 year postsurgery with no recurrence of severe hypoglycaemia, and he has good functional capacity and has returned to his office job. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26994053      PMCID: PMC4800221          DOI: 10.1136/bcr-2016-214702

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Malignant insulinoma: recommendations for characterisation and treatment.

Authors:  Eric Baudin; Philippe Caron; Catherine Lombard-Bohas; Antoine Tabarin; Emmanuel Mitry; Yves Reznick; David Taieb; François Pattou; Pierre Goudet; Delphine Vezzosi; Jean-Yves Scoazec; Guillaume Cadiot; Françoise Borson-Chazot; Christine Do Cao
Journal:  Ann Endocrinol (Paris)       Date:  2013-08-27       Impact factor: 2.478

Review 2.  Therapy for metastatic pancreatic neuroendocrine tumors.

Authors:  Roberta Elisa Rossi; Sara Massironi; Dario Conte; Maddalena Peracchi
Journal:  Ann Transl Med       Date:  2014-01

3.  Endogenous hyperinsulinemic hypoglycemia: diagnostic strategies, predictive features of malignancy and long-term survival.

Authors:  M Queiroz Almeida; M Cerqueira Cesar Machado; M L Correa-Giannella; D Giannella-Neto; M A Albergaria Pereira
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

4.  Risk factors for the occurrence of insulinoma: a case-control study.

Authors:  Han-Xiang Zhan; Lin Cong; Yu-Pei Zhao; Tai-Ping Zhang; Ge Chen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2013-06

5.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

Authors:  F J Service; M M McMahon; P C O'Brien; D J Ballard
Journal:  Mayo Clin Proc       Date:  1991-07       Impact factor: 7.616

6.  Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.

Authors:  Delphine Vezzosi; Antoine Bennet; Philippe Rochaix; Frédéric Courbon; Jannick Selves; Bernard Pradere; Louis Buscail; Christiane Susini; Philippe Caron
Journal:  Eur J Endocrinol       Date:  2005-05       Impact factor: 6.664

Review 7.  The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.

Authors:  David S Klimstra; Irvin R Modlin; Domenico Coppola; Ricardo V Lloyd; Saul Suster
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

8.  Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Authors:  Tetsuhide Ito; Hironobu Sasano; Masao Tanaka; R Yoshiyuki Osamura; Iwao Sasaki; Wataru Kimura; Koji Takano; Takao Obara; Miyuki Ishibashi; Kazuwa Nakao; Ryuichiro Doi; Akira Shimatsu; Toshirou Nishida; Izumi Komoto; Yukio Hirata; Kazuhiko Nakamura; Hisato Igarashi; Robert T Jensen; Bertram Wiedenmann; Masayuki Imamura
Journal:  J Gastroenterol       Date:  2010-02       Impact factor: 7.527

9.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

10.  Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.

Authors:  Tetsuhide Ito; Hisato Igarashi; Kazuhiko Nakamura; Hironobu Sasano; Takuji Okusaka; Koji Takano; Izumi Komoto; Masao Tanaka; Masayuki Imamura; Robert T Jensen; Ryoichi Takayanagi; Akira Shimatsu
Journal:  J Gastroenterol       Date:  2014-02-06       Impact factor: 7.527

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.